The nation of Zimbabwe has declined a significant American health deal valued at 367 million US dollars (£272m) spanning five years because of the United States' insistence on sensitive information.
This rejection came to light following a government memo from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesman later clarified that the US was demanding access to genetic material for research and profit but was not willing to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further negotiations to reach a deal acceptable to both sides so the country's critical HIV programme can continue.
Wider Implications
This rejection follows a comparable case in Kenya, where a court suspended a similar health funding agreement following concerns were raised about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance openness and accountability.
According to reports, Sixteen African countries have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our people should a new pandemic arise."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of bilateral health agreements were undermining frameworks previously set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to ongoing discussions with our US partners on how subsequent collaboration might be arranged in a way that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but urged that negotiations need to persist considering much of the country's HIV programmes were funded by external financing.
"If specific concerns exist, including those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it commented.
This impasse highlights the ongoing debate between accepting much-needed foreign assistance and protecting local interests in an ever more interconnected world.